Camber Capital Management Adds To Position In Genomic Health, Inc. (GHDX)

Stephen Dubois is optimistic about the prospects of Genomic Health, Inc. (NASDAQ:GHDX) and has increased his fund’s holding of the stock. As reported in a recent filing with the Securities and Exchange Commission, Dubois’ fund, Camber Capital Management, now holds 1.72 million shares, up from the 750,000 shares reported in its latest 13F filing. As a result, Camber and Dubois now have control over 5.52% of the Genomic Health’s common stock.

Genomic Health, Inc. (NASDAQ:GHDX)

Genomic Health, Inc. (NASDAQ:GHDX) has also attracted the attention of Ken Griffin and Israel Englander. During the first quarter of this year, Griffin’s Citadel Investment Group increased its holding of the stock by 28% to approximately 206,400 shares. Englander has also boosted his fund’s stake by 35%, taking it to 370,000 shares. Julian Baker and Felix Baker are also keeping tabs, with their fund, Baker Bros. Advisors, reporting ownership of 13.6 million shares in its latest 13F filing.

A provider of genomic-based clinical laboratory services, Genomic Health, Inc. (NASDAQ:GHDX) has seen its stock depreciate by 4% so far this year to a current price of $28.07 per share, which gives the company a market cap of $876 million. For the three months ending March 31, 2014, Genomic Health has reported revenues of $67 million, a year-over-year increase of 6.2% and a loss per share of $0.24. For the second quarter analysts estimate a loss of $0.26 per share and $69 million in revenues.

Dubois is also betting on Sequenom Inc. (NASDAQ:SQNM), having recently increased his fund’s stake to 6.30 million shares or 5.41% of the total number of shares outstanding. Another company Dubois sees value in is Cardica, Inc. (NASDAQ:CRDC). Camber Capital has reported a new position at the end of April, amassing 8.37 million shares, which account for approximately 10% of the common stock. The biggest equity position in Camber’s portfolio continues to be Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), although Dubois has decreased it by 18% during the first quarter of 2014 to 1.65 million shares.

Disclosure: none.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!